Porvair Filtration Group will be exhibiting its range at the Medica / CompaMed 2013 trade show in Düsseldorf, Germany.
On Stand F-08 in Hall 8a, Porvair will showcase regulatory approved BioVyon sintered porous plastic materials and its flagship product, Chromatrap, based upon proprietary BioVyon technology and used by researchers to identify cancer biomarkers.
BioVyon porous materials are used for in vitro filtration, separation, venting and wicking applications in the medical, pharmaceutical and life science industries.
Recent developments have included nasal spray filters, drug delivery filters and catheter vents.
Manufactured in ISO-accredited cleanrooms, BioVyon materials exhibit very low particle shedding, low extractables and low bio-burden, making them suited to critical applications.
The Chromatrap product, a novel chromatin immunoprecipitation (ChIP) assay, utilises BioVyon material to which Protein A or Protein G has been chemically bound.
Additionally, the Chromatrap solid phase porous structure captures antibody-tagged DNA-protein complexes associated with cancers.